ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
4 employees · est. 2007 · Toronto, Canada
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range of hard-to-treat cancers.
27 employees · est. 2022 · London, United Kingdom
ImmunoBiochem Corporation is the older company (2007 vs 2022); Pheon Therapeutics is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | ImmunoBiochem Corporation | Pheon Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2007 older | 2022 |
| Headquarters | ||
| Headquarters | Toronto, Canada | London, United Kingdom |
| Employees | ||
| Employees | 4 | 27 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | Not tracked yet | $188.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Development of Antibody-Drug Conjugates, Clinical Development of Cancer Therapies, Research in Oncology |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare Professionals, Oncologists, Cancer Treatment Centers, Pharmaceutical Distributors |
| Taxonomy | ||
| Taxonomy | Oncology, Biological Therapeutics, Cancer Research, Drug Development, Antibody-drug Conjugates, Tumor Microenvironment, Monoclonal Antibodies, Cytotoxic Drugs, Solid Tumors, Cancer Heterogeneity, Toronto Biomedical Hub, Research And Development, Innovations In Cancer Treatment | Antibody-Drug Conjugates (ADCs), Oncology, Hard-to-Treat Cancers, ADC Development, Monoclonal Antibodies, Proprietary Payload Platform, Drug Discovery, Solid Tumors, Novel Mechanism Of Action, Clinical Strategy, Medicinal Chemistry, Healthcare Investment, Pharmaceutical Research |
| Website | ||
| Website | immunobiochem.com | pheontx.com |
About ImmunoBiochem Corporation
ImmunoBiochem Corporation, a biotechnology company founded in 2007 and based in Ontario, Canada, is advancing the field of oncology therapeutics. With a commitment to addressing unmet medical needs, the company leverages its proprietary technology to tackle cancer heterogeneity in solid tumors throu...
About Pheon Therapeutics
Pheon Therapeutics, founded in 2022, is a promising player in the biotechnology, health and wellness, and life sciences sectors, with headquarters in the United Kingdom. The company specializes in developing next-generation Antibody-Drug Conjugates (ADCs) to tackle hard-to-treat cancers, as highligh...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at ImmunoBiochem Corporation and Pheon Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at ImmunoBiochem Corporat... and Pheon Therapeutics — by email.
Frequently Asked Questions
Compare ImmunoBiochem Corporation with someone else
Start typing a company name or domain.